RSS
CFDA
Registration fees for drugs and medical devices in China set to soar
China’s drug regulator has raised the fees to register drugs and medical devices in the world’s second-biggest pharmaceutical market, as a lack of resources and expertise hinders its ability to process a rising number of applications. more
Aesica Pharmaceuticals SrI collaborates with QAD to meet China’s FDA’s shortened serialisation deadline
Aesica Pharmaceuticals Srl, has launched a QAD integrated serialisation system to comply with change from China’s FDA at its site in Pianezza. The new requirements brought forward by CFDA cut the serialisation implementation deadline to just 3 months more
